Previous Article | Next Article 
Journal of Clinical Microbiology, February 1999, p. 376-379, Vol. 37, No. 2
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Limits in Reliability of Glycoprotein G-Based Type-Specific
Serologic Assays for Herpes Simplex Virus Types 1 and 2
D. Scott
Schmid,1,*
Denise R.
Brown,1
Rosane
Nisenbaum,2
Rae Lyn
Burke,3
D'Anna
Alexander,3
Rhoda
Ashley,4
Philip E.
Pellett,1 and
William C.
Reeves1
Division of Viral and Rickettsial Diseases,
Viral Exanthems and Herpesviruses Branch, National Center for
Infectious Diseases, Centers for Disease Control and Prevention,
Atlanta, Georgia 303331;
Klemm Analysis
Group, Atlanta, Georgia 303452;
Chiron Vaccines, Chiron Corporation, Emeryville, California
946083; and
Children's Hospital,
University of Washington, Seattle, Washington
981054
Received 20 August 1998/Returned for modification 7 October
1998/Accepted 18 November 1998
Type-specific serologic assays for herpes simplex virus (HSV) types
1 and 2 based on glycoprotein G-1 (gG-1) (HSV-1) and gG-2 (HSV-2)
discriminate between antibodies against HSV-1 and HSV-2. We previously
developed a Western blot assay using gG-1 and gG-2 expressed in
baculovirus, performed extensive validation studies, and determined
that it was both sensitive and specific for type-specific detection of
HSV antibody. Here we report that, among a cohort of Thai military
recruits, the serostatus of some individuals changed from positive to
negative over time (6.6% among those ever positive for HSV-1, and
14.9% among those ever positive for HSV-2). We tested a subset of
these specimens in three other gG-based assays: an enzyme-linked
immunosorbent assay, an immunoblot strip assay, and a Western blot
assay. Positive-to-negative shifts occurred in every assay; the
frequency of the shifts ranged from 6.1% to 21.2% of the specimen
sets tested. There was only limited agreement among the assays
concerning which individuals lost reactivity. This inaccuracy,
exhibited by all of the assay protocols, was not predicted by
validation studies employing specimens from cross-sectional studies and
was most pronounced in HSV-2 testing. This argues for the inclusion of
serial blood specimens in serologic assay validation procedures.
*
Corresponding author. Mailing address: CDC, NCID,
Division of Viral and Rickettial Diseases, Viral Exanthems and
Herpesvirus Branch, 1600 Clifton Rd., MSD-10, Atlanta GA 30333. Phone:
(404) 639-0066. Fax: (404) 639-4056. E-mail: dss1{at}cdc.gov.
Journal of Clinical Microbiology, February 1999, p. 376-379, Vol. 37, No. 2
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Chentoufi, A. A., Binder, N. R., Berka, N., Durand, G., Nguyen, A., Bettahi, I., Maillere, B., BenMohamed, L.
(2008). Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B. J. Virol.
82: 11792-11802
[Abstract]
[Full Text]
-
Zhang, X., Castelli, F. A., Zhu, X., Wu, M., Maillere, B., BenMohamed, L.
(2008). Gender-Dependent HLA-DR-Restricted Epitopes Identified from Herpes Simplex Virus Type 1 Glycoprotein D. CVI
15: 1436-1449
[Abstract]
[Full Text]
-
Chentoufi, A. A., Zhang, X., Lamberth, K., Dasgupta, G., Bettahi, I., Nguyen, A., Wu, M., Zhu, X., Mohebbi, A., Buus, S., Wechsler, S. L., Nesburn, A. B., BenMohamed, L.
(2008). HLA-A*0201-Restricted CD8+ Cytotoxic T Lymphocyte Epitopes Identified from Herpes Simplex Virus Glycoprotein D. J. Immunol.
180: 426-437
[Abstract]
[Full Text]
-
Pebody, R G, Andrews, N, Brown, D, Gopal, R, de Melker, H, Francois, G, Gatcheva, N, Hellenbrand, W, Jokinen, S, Klavs, I, Kojouharova, M, Kortbeek, T, Kriz, B, Prosenc, K, Roubalova, K, Teocharov, P, Thierfelder, W, Valle, M, Van Damme, P, Vranckx, R
(2004). The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex. Transm. Infect.
80: 185-191
[Abstract]
[Full Text]
-
Wales, S. Q., Smith, C. C., Wachsman, M., Calton, G., Aurelian, L.
(2004). Performance and Use of a Ribonucleotide Reductase Herpes Simplex Virus Type-Specific Serological Assay. CVI
11: 42-49
[Abstract]
[Full Text]
-
Gorander, S., Svennerholm, B., Liljeqvist, J.-A.
(2003). Secreted Portion of Glycoprotein G of Herpes Simplex Virus Type 2 Is a Novel Antigen for Type-Discriminating Serology. J. Clin. Microbiol.
41: 3681-3686
[Abstract]
[Full Text]
-
Lai, W, Chen, C Y, Morse, S A, Htun, Y., Fehler, H G, Liu, H, Ballard, R C
(2003). Increasing relative prevalence of HSV-2 infection among men with genital ulcers from a mining community in South Africa. Sex. Transm. Infect.
79: 202-207
[Abstract]
[Full Text]
-
Cherpes, T. L., Ashley, R. L., Meyn, L. A, Hillier, S. L.
(2003). Longitudinal Reliability of Focus Glycoprotein G-Based Type-Specific Enzyme Immunoassays for Detection of Herpes Simplex Virus Types 1 and 2 in Women. J. Clin. Microbiol.
41: 671-674
[Abstract]
[Full Text]
-
Fisman, D N, Hook, E W III, Goldie, S J
(2003). Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2. Sex. Transm. Infect.
79: 45-52
[Abstract]
[Full Text]
-
Ikoma, M., Liljeqvist, J.-A., Groen, J., Glazenburg, K. L., The, T. H., Welling-Wester, S.
(2002). Use of a Fragment of Glycoprotein G-2 Produced in the Baculovirus Expression System for Detecting Herpes Simplex Virus Type 2-Specific Antibodies. J. Clin. Microbiol.
40: 2526-2532
[Abstract]
[Full Text]
-
Eing, B. R., Lippelt, L., Lorentzen, E. U., Hafezi, W., Schlumberger, W., Steinhagen, K., Kuhn, J. E.
(2002). Evaluation of Confirmatory Strategies for Detection of Type-Specific Antibodies against Herpes Simplex Virus Type 2. J. Clin. Microbiol.
40: 407-413
[Abstract]
[Full Text]
-
Liljeqvist, J.-A., Trybala, E., Hoebeke, J., Svennerholm, B., Bergstrom, T.
(2002). Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants. J. Gen. Virol.
83: 157-165
[Abstract]
[Full Text]
-
Ashley, R. L
(2001). Sorting out the new HSV type specific antibody tests. Sex. Transm. Infect.
77: 232-237
[Abstract]
[Full Text]
-
Armstrong, G. L., Schillinger, J., Markowitz, L., Nahmias, A. J., Johnson, R. E., McQuillan, G. M., St. Louis, M. E.
(2001). Incidence of Herpes Simplex Virus Type 2 Infection in the United States. Am J Epidemiol
153: 912-920
[Abstract]
[Full Text]
-
Van Doornum, G. J. J., Slomka, M. J., Buimer, M., Groen, J., Van den Hoek, J. A. R., Cairo, I., Vyse, A., Brown, D. W. G.
(2000). Comparison of a Monoclonal Antibody-Blocking Enzyme-Linked Immunoassay and a Strip Immunoblot Assay for Identifying Type-Specific Herpes Simplex Virus Type 2 Serological Responses. CVI
7: 641-644
[Abstract]
[Full Text]
-
Rekabdar, E., Tunback, P., Liljeqvist, J.-A., Bergstrom, T.
(1999). Variability of the Glycoprotein G Gene in Clinical Isolates of Herpes Simplex Virus Type 1. CVI
6: 826-831
[Abstract]
[Full Text]